This content is current only at the time of printing. This document was printed on 9 May 2021. A current copy is located at https://apvma.gov.au/node/29476
You are here
Regulatory Update #270
APVMA achieves another quarter of performance improvement
Our operational performance has improved for the third consecutive quarter.
Our performance statistics from January—March were released on Monday 30 April and show that 79 per cent of assessments were finalised on time. This is up from 74 per cent during the previous quarter.
You can view the latest performance statistics on our website.
World-first access for Australian farmers following APVMA agvet chemical approval
Australian farmers are the first in the world to have access to agvet chemicals afidopyropen and Duddingtonia flagrans following registration last month.
Afidopyropen is an insecticide to aid in the control of aphids and silverleaf whitefly in cotton and vegetables. Duddingtonia flagrans is a biological present as a palatable feed supplement used to treat parasitic gastrointestinal nematodes of grazing animals.
Registration of these two chemicals means that Australian farmers now have access to new safe and effective pest management tools for use in vegetable, cotton and livestock production.
More information about this world-first chemical approval is available on our website.
Seeking input on the Risk Assessment Manual for Chemistry and Manufacture
The APVMA Risk Manual for Chemistry and Manufacture is now open for public consultation. The manual outlines the assessment approaches we use to evaluate chemistry and manufacture data. It is intended as a guidance document for both the APVMA and stakeholders.
This revised version of the manual includes explanatory notes to aid understanding for how, what and why specific data is used and how this data relates to the Agvet Code and Regulations.
Consultation details are available on our website. Please submit your comments before close of business Thursday 24 May 2018.
Join our team—submit your application now
We are currently looking to fill two SES1 vacancies in Armidale in the following positions:
- Executive Director, Scientific and Risk Capability; and
- Chief Regulatory Scientist.
Our senior executive provide leadership across the APVMA and ensure that our scientific expertise, risk management, planning, policies and systems enhance our decision making capability and capacity.
Visit our careers page for more information about these opportunities.
Strong participation in APVMA client and stakeholder survey
Thank you to all who participated in our recent client and stakeholder survey.
The responses reflect the strong engagement of industry with our agency. We value your interest in working with us to improve client services and stakeholder engagement.
Data from this year’s survey will be used to report on our achievements and progress in areas of client service and stakeholder engagement, and to establish new targets for these areas in key publications such as our corporate and operational plans for 2018–19.
High level results will be shared on our website in the coming months. We will notify you via the Regulatory Update when this occurs.
Development approval granted for permanent building in Armidale
We’re another step closer to doors opening at our permanent premises in Armidale, with development approval granted on 29 March 2018 for the building site of our future office.
Stirloch developments have established a site office, and are now preparing for demolition and excavation work. Watch this space for further updates as the construction commences.
Reminder—open for public consultation
We regularly seek input throughout chemical registration and review processes, and other operational and regulatory processes. We are currently seeking input on the following open consultations:
- Proposed approval of the new active eimeria brunetti strain roybru3+28 in the product Eimeriavax plus vaccine - 22 May 2018
- Proposed approval of the new active amlodipine besilate in the product Amodip Flavoured Tablets for Cats - 22 May 2018
- Proposed approval of the new active lokivetmab in the products Cytopoint Solution for Injection for Dogs - 22 May 2018
- Proposed approval of the new active lotilaner in the products Credelio Chewable Tablets for Dogs - 22 May 2018
- Proposed approval of the new product Toad Blitz Cane Toad Killer containing eugenol - 22 May 2018
- Seeking input on the Risk Assessment Manual for Chemistry and Manufacture - 24 May 2018
- Phone our general enquiries number: +61 2 6210 4701
- Email: email@example.com
- Our mailing address is:
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston, Australian Capital Territory 2604
Add us to your address book